天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

Belzutifan

Belzutifan Struktur
1672668-24-4
CAS-Nr.
1672668-24-4
Englisch Name:
Belzutifan
Synonyma:
Belzutifan;PT2977;MK-6482;Betivan.;PT2977 (MK-6482);PT2977 Belzutifan;Belzutifan (PT2977);Belzutifan (MK-6482);Belzutifan, 10 mM in DMSO;Belzutifan/MK-6482/PT2977
CBNumber:
CB75488378
Summenformel:
C17H12F3NO4S
Molgewicht:
383.34
MOL-Datei:
1672668-24-4.mol

Belzutifan Eigenschaften

Siedepunkt:
505.8±50.0 °C(Predicted)
Dichte
1.56±0.1 g/cm3(Predicted)
storage temp. 
Store at -20°C, stored under nitrogen
L?slichkeit
DMSO: 50 mg/mL (130.43 mM)
Aggregatzustand
Solid
pka
11.66±0.60(Predicted)
Farbe
White to light yellow
Sicherheit
  • Risiko- und Sicherheitserkl?rung
  • Gefahreninformationscode (GHS)
Bildanzeige (GHS) GHS hazard pictogramsGHS hazard pictograms
Alarmwort Warnung
Gefahrenhinweise
Code Gefahrenhinweise Gefahrenklasse Abteilung Alarmwort Symbol P-Code
H361 Kann vermutlich die Fruchtbarkeit beeintr?chtigen oder das Kind im Mutterleib sch?digen. Reproduktionstoxizit?t Kategorie 2 Warnung P201, P202, P281, P308+P313, P405,P501
H373 Kann die Organe sch?digen bei l?ngerer oder wiederholter Exposition. Spezifische Zielorgan-Toxizit?t (wiederholte Exposition) Kategorie 2 Warnung P260, P314, P501
H411 Giftig für Wasserorganismen, mit langfristiger Wirkung. Langfristig (chronisch) gew?ssergef?hrdend Kategorie 2
Sicherheit
P201 Vor Gebrauch besondere Anweisungen einholen.
P202 Vor Gebrauch alle Sicherheitshinweise lesen und verstehen.
P260 Dampf/Aerosol/Nebel nicht einatmen.
P281 Vorgeschriebene pers?nliche Schutzausrüstung verwenden.
P308+P313 BEI Exposition oder falls betroffen: ?rztlichen Rat einholen/?rztliche Hilfe hinzuziehen.
P314 Bei Unwohlsein ?rztlichen Rat einholen / ?rztliche Hilfe hinzuziehen.
P405 Unter Verschluss aufbewahren.
P501 Inhalt/Beh?lter ... (Entsorgungsvorschriften vom Hersteller anzugeben) zuführen.

Belzutifan Chemische Eigenschaften,Einsatz,Produktion Methoden

Beschreibung

Belzutifan is an orally active, small molecule inhibitor of hypoxia inducible factor (HIF)-2alpha (HIF-2a), with potential antineoplastic activity. The HIF-2α protein was a key player in the growth of certain cancers. Initially considered to be undruggable, a binding pocket was eventually discovered in the HIF-2α molecule which allowed for compounds to bind and inhibit these proteins. 

Synthese

Belzutifan’s route started with 3,4-dihydrocoumarin (33.1) and proceeded in three steps:
Step 1: Synthesis of the indanone core 33.8. 3,4-Dihydrocoumarin (33.1) could be regioselectively brominated with NBS under Lewis acid conditions to generate intermediate 33.2, paving the way for the subsequent tandem lactone ring opening/SNAr reaction (Figure 1). The desired ring-opening product was successfully generated by treating 33.2 with K2CO3 in NMP and H2O, which spontaneously participated in the SNAr reaction in the presence of 3,5-difluorobenzonitrile (33.3) and 18-crown-6 to generate intermediate 33.5. After isopropanoate (i-PrOAc) extraction, the crude product was reacted with oxalyl chloride in MTBE/DMF to generate the corresponding acyl chloride 33.6, which underwent an intramolecular Friedel–Crafts reaction in the presence of AlCl3. This series of reactions started with the bromination of intermediate 33.2 to generate indanone 33.7. The introduction of methyl sulfone was achieved using sodium methanesulfonate under copper-mediated conditions to generate 33.8 in 78% yield.
Figure 1. Synthesis of the indanone core 33.8
Step 2: Synthesis of indanone ketal 33.13. Starting from indanone 33.8, the keto group was protected to its corresponding ketal intermediate 33.9 before developing a continuous-flow light-mediated benzylic bromination step (Figure 2). Thus, intermediate 33.11 could be free-radical brominated with 1,3-dibromo-5,5-dimethylhydantoin (33.10) in acetonitrile in the presence of citric acid and visible light to generate a crude reaction mixture that was carefully quenched with 2,6-butane and 1,3-dimethoxybenzene. The brominated product 33.11, which showed limited stability when isolated, was directly oxidized in a continuous flow process to generate the ketone 33.13 via a modified Kornblum oxidation with 2-methylpyridine N-oxide (33.12).
Figure 2. Synthesis of indanone ketal 33.13
Step 3: The presence of three consecutive chiral centers on the indene ring was ensured. First, the introduction of the chiral alcohol 33.14 was accomplished by asymmetric reduction under transfer hydrogenation conditions using (R,R)-Ru-diphenylethylenediamine ((R,R)-Ru-DPEN) and formic acid/triethylamine in acetonitrile to afford the (R)-hydroxyketone with high selectivity (Figure 3). The reduction step was immediately quenched with aqueous hydrochloric acid to promote the cleavage of the acetal group, resulting in the crystallization of intermediate 33.14 from water in 91% overall yield and greater than 99% enantiomeric excess. Next, intermediate 33.14 was α-fluorinated by reaction with Selectfluor and catalytic methanesulfonic acid to generate a mixture of fluorinated stereoisomers (33.15), which immediately underwent Noyori asymmetric transfer hydrogenation after quenching the excess fluorinating agent with triethylamine. Under these hydrogenation conditions (RuCl(R,R)-TsDPEN/triethylamine/formic acid/methanesulfonic acid), the reduction of the ketone occurred with high selectivity while promoting the dynamic kinetic resolution (DKR) of the adjacent fluorinated substituents in a one-pot reaction. Although acid-mediated acetal byproducts were observed in this reaction sequence, the desired stereoisomer 33.16 was isolated from 33.14 in 80% yield (99:1 enantiomeric ratio) by quenching the reaction with water. Finally, the final stereocenter was established by deoxyfluorination of intermediate 33.16 using perfluoro-1-butanesulfonyl fluoride (PBSF, 33.17). In this reaction, selective deprotonation of the desired alcohol using DBU was crucial. This reaction completely reversed the stereochemistry and afforded Belzutifan (33) in 73% yield and 99.8% purity by recrystallization from water.
Figure 3. Synthesis of Belzutifan

Belzutifan Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Belzutifan Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 100)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Nantong HI-FUTURE Biology Co., Ltd.
+undefined18051384581
sales@chemhifuture.com China 3135 58
ATK CHEMICAL COMPANY LIMITED
+undefined-21-51877795
ivan@atkchemical.com China 33024 60
TargetMol Chemicals Inc.
+17819995354
marketing@targetmol.com United States 32282 58
Zhejiang J&C Biological Technology Co.,Limited
+1-2135480471 +1-2135480471
sales@sarms4muscle.com China 10473 58
InvivoChem
+1-708-310-1919 +1-13798911105
sales@invivochem.cn United States 6391 58
Hebei Miaoyin Technology Co.,Ltd
+86-17367732028 +86-17367732028
kathy@hbyinsheng.com China 3512 58
Zibo Hangyu Biotechnology Development Co., Ltd
+86-0533-2185556 +8615965530500
nickzhang@hangyubiotech.com China 10968 58
LEAPCHEM CO., LTD.
+86-852-30606658
market18@leapchem.com China 43340 58
Sichuan Biosynce Pharmatech Co., Ltd.
+8619950309693
diane@biosynce.com China 4871 58
R&D Scientific Inc.
+1-2266000236
sales@rdscientific.com Canada 1822 58

  • Benzonitrile, 3-[[(1S,2S,3R)-2,3-difluoro-2,3-dihydro-1-hydroxy-7-(methylsulfonyl)-1H-inden-4-yl]oxy]-5-fluoro-
  • PT2977 (MK-6482)
  • Belzutifan (MK-6482)
  • Belzutifan (PT2977, MK-6482)
  • HY-125840 Belzutifan PT2977
  • PT2977
  • MK-6482
  • Belzutifan
  • 3-(((1S,2S,3R)-2,3-Difluoro-1-hydroxy-7-(methylsulfonyl)-2,3-dihydro-1H-inden-4-yl)oxy)-5-fluorobenzonitrile
  • Belzutifan (PT2977)
  • Belzutifan,PT-2977,Inhibitor,MK6482,PT 2977,HIFs,MK 6482,HIF/HIF Prolyl-Hydroxylase,inhibit,HIF-PH,Hypoxia-inducible factors
  • PT2977 Belzutifan
  • 3-[(1S,2S,3R)-2,3-difluoro-1-hydroxy-7-methylsulfonyl-indan-4-yl]oxy-5-fluoro-benzonitrile
  • Betivan.
  • Belzutifan, 10 mM in DMSO
  • Belzutifan/MK-6482/PT2977
  • 1672668-24-4
Copyright 2019 ? ChemicalBook. All rights reserved